Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Proc Natl Acad Sci U S A ; 113(8): 2146-51, 2016 Feb 23.
Artigo em Inglês | MEDLINE | ID: mdl-26858405

RESUMO

Epigenetic modifications play significant roles in adaptive evolution. The tumor suppressor p53, well known for controlling cell fate and maintaining genomic stability, is much less known as a master gene in environmental adaptation involving methylation modifications. The blind subterranean mole rat Spalax eherenbergi superspecies in Israel consists of four species that speciated peripatrically. Remarkably, the northern Galilee species Spalax galili (2n = 52) underwent adaptive ecological sympatric speciation, caused by the sharply divergent chalk and basalt ecologies. This was demonstrated by mitochondrial and nuclear genomic evidence. Here we show that the expression patterns of the p53 regulatory pathway diversified between the abutting sympatric populations of S. galili in sharply divergent chalk-basalt ecologies. We identified higher methylation on several sites of the p53 promoter in the population living in chalk soil (chalk population). Site mutagenesis showed that methylation on these sites linked to the transcriptional repression of p53 involving Cut-Like Homeobox 1 (Cux1), paired box 4 (Pax 4), Pax 6, and activator protein 1 (AP-1). Diverse expression levels of p53 between the incipiently sympatrically speciating chalk-basalt abutting populations of S. galili selectively affected cell-cycle arrest but not apoptosis. We hypothesize that methylation modification of p53 has adaptively shifted in supervising its target genes during sympatric speciation of S. galili to cope with the contrasting environmental stresses of the abutting divergent chalk-basalt ecologies.


Assuntos
Metilação de DNA , Genes p53 , Spalax/genética , Spalax/metabolismo , Adaptação Biológica , Animais , Carbonato de Cálcio , Pontos de Checagem do Ciclo Celular/genética , Ecossistema , Evolução Molecular , Expressão Gênica , Especiação Genética , Genética Populacional , Pulmão/metabolismo , Regiões Promotoras Genéticas , Silicatos , Solo , Spalax/classificação , Simpatria
2.
Proc Natl Acad Sci U S A ; 111(36): 13199-204, 2014 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-25146699

RESUMO

Cerebral edema is a potentially life-threatening illness, but knowledge of its underlying mechanisms is limited. Here we report that hypobaric hypoxia induces rat cerebral edema and neuronal apoptosis and increases the expression of corticotrophin releasing factor (CRF), CRF receptor type 1 (CRFR1), aquaporin-4 (AQP4), and endothelin-1 (ET-1) in the cortex. These effects, except for the increased expression of CRF itself, could all be blocked by pretreatment with an antagonist of the CRF receptor CRFR1. We also show that, in cultured primary astrocytes: (i) both CRFR1 and AQP4 are expressed; (ii) exogenous CRF, acting through CRFR1, triggers signaling of cAMP/PKA, intracellular Ca(2+), and PKCε; and (iii) the up-regulated cAMP/PKA signaling contributes to the phosphorylation and expression of AQP4 to enhance water influx into astrocytes and produces an up-regulation of ET-1 expression. Finally, using CHO cells transfected with CRFR1(+) and AQP4(+), we show that transfected CRFR1(+) contributes to edema via transfected AQP4(+). In conclusion, hypoxia triggers cortical release of CRF, which acts on CRFR1 to trigger signaling of cAMP/PKA in cortical astrocytes, leading to activation of AQP4 and cerebral edema.


Assuntos
Aquaporina 4/metabolismo , Edema Encefálico/etiologia , Edema Encefálico/metabolismo , Hipóxia/complicações , Receptores de Hormônio Liberador da Corticotropina/metabolismo , Animais , Apoptose/genética , Aquaporina 4/genética , Astrócitos/metabolismo , Edema Encefálico/patologia , Células CHO , Hormônio Liberador da Corticotropina/metabolismo , Cricetinae , Cricetulus , Endotelina-1/metabolismo , Hipóxia/metabolismo , Hipóxia/patologia , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Masculino , Neurônios/metabolismo , Neurônios/patologia , Fosforilação , Ratos Sprague-Dawley , Transdução de Sinais , Transfecção , Regulação para Cima/genética
3.
Proc Natl Acad Sci U S A ; 110(51): 20639-44, 2013 Dec 17.
Artigo em Inglês | MEDLINE | ID: mdl-24297887

RESUMO

Mutational changes in p53 correlate well with tumorigenesis. Remarkably, however, relatively little is known about the role that p53 variations may play in environmental adaptation. Here we report that codon asparagine-104 (104N) and glutamic acid-104 (104E), respectively, of the p53 gene in the wild zokor (Myospalax baileyi) and root vole (Microtus oeconomus) are adaptively variable, meeting the environmental stresses of the Tibetan plateau. They differ from serine-104 (104S) seen in other rodents, including the lowland subterranean zokor Myospalax cansus, and from serine 106 (106S) in humans. Based on site-directed mutational analysis in human cell lines, the codon 104N variation in M. baileyi is responsible for the adaptive balance of the transactivation of apoptotic genes under hypoxia, cold, and acidic stresses. The 104E p53 variant in Microtus oeconomus suppresses apoptotic gene transactivation and cell apoptosis. Neither 104N nor 104E affects the cell-cycle genes. We propose that these variations in p53 codon 104 are an outcome of environmental adaptation and evolutionary selection that enhance cellular strategies for surviving the environmental stresses of hypoxia and cold (in M. baileyi and M. oeconomus) and hypercapnia (in M. baileyi) in the stressful environments of the Qinghai-Tibet plateau.


Assuntos
Adaptação Fisiológica/genética , Apoptose/genética , Arvicolinae/genética , Temperatura Baixa , Evolução Molecular , Hipóxia/genética , Estresse Fisiológico/genética , Proteína Supressora de Tumor p53/genética , Animais , Arvicolinae/metabolismo , Humanos , Hipóxia/metabolismo , Tibet , Ativação Transcricional/genética , Proteína Supressora de Tumor p53/metabolismo
5.
Asian Pac J Cancer Prev ; 15(1): 111-6, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24528010

RESUMO

OBJECTIVE: To study potential targets of Danshensu via dual inverse docking. METHOD: PharmMapper and idTarget servers were used as tools, and the results were checked with the molecular docking program autodock vina in PyRx 0.8. RESULT: The disease-related target HRas was rated top, with a pharmacophore model matching well the molecular features of Danshensu. In addition, docking results indicated that the complex was also matched in terms of structure, H-bonds, and hydrophobicity. CONCLUSION: Dual inverse docking indicates that HRas may be a potential anticancer target of Danshensu. This approach can provide useful information for studying pharmacological effects of agents of interest.


Assuntos
Antineoplásicos Fitogênicos/metabolismo , Lactatos/metabolismo , Proteínas/metabolismo , Software , Antineoplásicos Fitogênicos/química , Sítios de Ligação , Bases de Dados de Proteínas , Desenho de Fármacos , Humanos , Internet , Lactatos/química , Ligantes , Ligação Proteica , Proteínas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA